TheEdgeResearch
Home / Stocks / PRVCF

PreveCeutical Medical Inc. (PRVCF)

OTC Healthcare Biotechnology
$0.01 ▲ +5.02%
Market Cap
$8.0M
Sector
Healthcare
Industry
Biotechnology
Beta
0.07
52-Wk Range
0.0037-0.0279
CEO
Stephen Van Deventer
Country
CA
Currency
USD

PreveCeutical Medical Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.01, up 5.02% on the session, giving a market capitalisation of $8.0M. On trailing twelve-month figures it carries a trailing P/E of -16.67, a net margin of 0.0%. Its beta of 0.07 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-16.67
Price / Sales
0.00
Price / Book
-1.80
EV / EBITDA
-64.48
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-0.72
Current ratio
0.16
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
7
IPO date
2017-08-21
Headquarters
Vancouver, BC, CA
About PreveCeutical Medical Inc.

PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.

More research on PRVCF
PRVCF technical analysis PRVCF TheEdge Score Compare against peers
Open full interactive analysis & DCF →